UBS Group’s BrightSpring Health Services BTSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$43.5M Buy
623,476
+69,816
+13% +$3.88M 0.01% 1885
2026
Q1
$23.6M Sell
553,660
-90,800
-14% -$3.66M ﹤0.01% 2406
2025
Q4
$24.1M Sell
644,460
-20,266
-3% -$680K ﹤0.01% 2405
2025
Q3
$19.6M Sell
664,726
-52,885
-7% -$1.23M ﹤0.01% 2590
2025
Q2
$16.9M Buy
717,611
+498,197
+227% +$10.4M ﹤0.01% 2548
2025
Q1
$3.97M Sell
219,414
-105,521
-32% -$2.07M ﹤0.01% 4025
2024
Q4
$5.53M Buy
324,935
+198,229
+156% +$3.43M ﹤0.01% 3729
2024
Q3
$1.86M Buy
126,706
+35,649
+39% +$447K ﹤0.01% 4066
2024
Q2
$1.03M Buy
91,057
+36,838
+68% +$402K ﹤0.01% 4398
2024
Q1
$589K Buy
+54,219
New +$542K ﹤0.01% 5068

Other funds holding BTSG

UBS Group's BTSG Position: Q2 2026 in Review

UBS Group increased its BrightSpring Health Services (BTSG) stake by 13% in Q2 2026, buying an estimated $3.88M and bringing the position to 623,476 shares worth $43.5M. The position accounts for 0.01% of the portfolio, ranked #1885.

UBS Group first reported a position in BTSG in Q1 2024 and has held it in 10 quarters since. 423 funds tracked by Wall St. Rank hold BTSG as of Q2 2026.

  • UBS Group held 623,476 shares of BrightSpring Health Services worth $43.5M as of Q2 2026.
  • UBS Group bought 69,816 BrightSpring Health Services shares in Q2 2026, an estimated $3.88M.
  • BrightSpring Health Services made up 0.01% of UBS Group's portfolio in Q2 2026, its #1885 holding.
  • UBS Group first reported a position in BrightSpring Health Services in Q1 2024 and has held it in 10 quarters since.
  • 423 funds tracked by Wall St. Rank held BrightSpring Health Services as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.